undamentalytics Newsletter

Miller Marc D: insider trades

Chief executive, Officer at Universal Health Services. No open-market purchases and 18 sales not made under a pre-set plan, reported from March 10, 2010 to May 12, 2023.

What happened after Miller Marc D’s sales?

After their sales, the shares moved +19.9% against the index over 12 months on average (a negative figure means selling was the right call); 11% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Miller Marc D: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 18 +6.4% +5.6% 33% 7 −0.03 0.98 No reliable evidence
Sales, 12 months after the report 18 +19.9% +19.4% 11% 7 0.80 0.46 No reliable evidence
Sales, 12 months after the trade 18 +20.3% +19.1% 17% 7 0.68 0.52 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Universal Health Services UHS President and CEO018March 10, 2010May 12, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 12, 2023May 10, 2023 UHS Sale $6,292,228 −12.8%+2.6%−1.4%
December 13, 2019December 12, 2019 UHS Sale $1,157,959 −27.6%−22.0%−27.1%
September 15, 2014September 12, 2014 UHS Sale $669,920 −4.9%+20.2%+21.1%
May 15, 2014May 14, 2014 UHS Sale $728,005 +24.7%+33.2%+28.2%
December 16, 2013December 13, 2013 UHS Sale $808,848 −9.9%+16.8%+17.1%
November 13, 2013November 12, 2013 UHS Sale $940,294 0.0%+5.5%+5.5%
June 18, 2013June 14, 2013 UHS Sale $2,118,100 +1.4%+18.6%+13.5%
May 16, 2013May 15, 2013 UHS Sale $1,027,650 +4.3%+13.3%+8.2%
March 15, 2013March 14, 2013 UHS Sale $2,765,250 +6.8%+1.6%+1.5%
March 8, 2013March 8, 2013 UHS Sale $408,100 +11.5%+5.8%+7.7%
December 17, 2012December 14, 2012 UHS Sale $552,360 +21.8%+40.0%+49.3%
December 14, 2012December 13, 2012 UHS Sale $413,970 +25.5%+46.2%+50.1%
December 13, 2012December 12, 2012 UHS Sale $463,200 +27.3%+49.3%+50.7%
December 10, 2012December 7, 2012 UHS Sale $410,940 +24.2%+49.6%+53.9%
December 5, 2012December 4, 2012 UHS Sale $901,000 +21.2%+51.5%+57.3%
March 16, 2012March 14, 2012 UHS Sale $3,625,908 −5.7%+30.7%+30.8%
June 15, 2011June 14, 2011 UHS Sale $1,575,600 −22.3%−31.0%−29.9%
March 10, 2010March 9, 2010 UHS Sale $2,462,000 +29.7%+26.5%+29.0%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Miller Marc D traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.